On March 7, 2024, an LSD formula (MM120) was granted Breakthrough Therapy Status by the FDA. According to the FDA, the “Breakthrough Therapy Status” designation requires preliminary clinical evidence that demonstrates the drug may have substantial improvement on at least one clinically significant endpoint over available therapy. This also means the LSD formula has received…
Attention mental healthcare providers! Exciting news in the world of mental health therapy. On December 12, 2023, MAPS Public Benefit Corporation filed the first New Drug Application for any psychedelic-assisted therapy. If approved, MDMA-assisted therapy would be the first psychedelic-assisted therapy approved for PTSD. This would require the DEA to reschedule MDMA, making it available…
As a result of the COVID-19 pandemic, many clients are feeling a sense of urgency about implementing a new or updated will, trust, power of attorney, health proxy or other estate planning vehicle. An understandable concern is how to safely implement such a plan while still abiding by social distancing guidelines. In both New York…
David E. Daniels, Managing Partner at Daniels, Porco & Lusardi, LLP was recently selected by his peers for inclusion in The Best Lawyers in America, 25th edition in the field of Health Care Law. Daniels has been recognized on the list since 2012. Since it was first published in 1983, Best Lawyers® has become universally…